The relation of Erythropoietin and soluble erythropoietin receptor for Pregnancy-specific disease

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1900025193

Enrollment

Unknown

Registered

2019-08-16

Start date

2017-06-08

Completion date

Unknown

Last updated

2019-08-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnancy-specific disease

Interventions

Four groups:none

Eligibility

Sex/Gender

Female

Age

25 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1. Normal group: Scar uterus, selective cesarean section; 2. ICP group: TBA10umol/l AST/ALT two double of normal or Clinical diagnosis of ICP 3. Pre-eclampsia groupSBP>140mmhg, DBP>90mmhg after 20 weeks of gestation, Urinary protein 300mg/24h (or >= +positive). 4. GDM group: FPG >5.1 mmol/l; 10 mmol/l one hour after meal, or 8.5mmol two hours after meal.

Exclusion criteria

Exclusion criteria: 1. HB <100g or hypoxemia in the first trimester of pregnancy; 2. liver disease and hepatitis; 3. amniotic fluid contamination; 4. fetal intrauterine growth restriction; 5. teratogenic; 6. premature rupture of membranes; 7. hemolytic disease.

Design outcomes

Primary

Measure	Time frame
EPO;sEPOR;cord blood gas;	—

Secondary

Measure	Time frame
Pregnant women blood biochemistry;	—

Countries

China

Contacts

Public ContactLin Xuemei

West China Second Hospital of Sichuan University

xuemeilinscu@163.com+86 18180609220

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026